X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1002) 1002
Publication (114) 114
Dissertation (8) 8
Book Chapter (7) 7
Book Review (5) 5
Magazine Article (5) 5
Conference Proceeding (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (718) 718
fenretinide (533) 533
oncology (467) 467
fenretinide - pharmacology (435) 435
female (365) 365
animals (334) 334
apoptosis (314) 314
index medicus (268) 268
antineoplastic agents - pharmacology (256) 256
apoptosis - drug effects (239) 239
fenretinide - therapeutic use (205) 205
male (172) 172
mice (172) 172
cancer (169) 169
cell line, tumor (167) 167
tumor cells, cultured (158) 158
biochemistry & molecular biology (154) 154
n-retinamide (154) 154
retinoids (143) 143
breast-cancer (137) 137
rats (130) 130
neuroblastoma (129) 129
tretinoin - pharmacology (125) 125
chemoprevention (121) 121
tretinoin - analogs & derivatives (118) 118
retinoic acid (117) 117
expression (115) 115
middle aged (115) 115
fenretinide - administration & dosage (108) 108
induction (108) 108
antineoplastic agents - therapeutic use (102) 102
4-hpr (98) 98
dose-response relationship, drug (98) 98
cell division - drug effects (97) 97
cell biology (95) 95
adult (94) 94
prevention (89) 89
pharmacology & pharmacy (88) 88
differentiation (84) 84
aged (81) 81
anticarcinogenic agents - therapeutic use (79) 79
reactive oxygen species - metabolism (79) 79
acid (74) 74
anticarcinogenic agents - pharmacology (73) 73
breast cancer (69) 69
breast neoplasms - prevention & control (68) 68
inhibition (68) 68
article (67) 67
neuroblastoma - drug therapy (65) 65
research (65) 65
cell survival - drug effects (63) 63
flow cytometry (63) 63
time factors (63) 63
lines (62) 62
death (61) 61
growth (61) 61
n- retinamide (61) 61
synthetic retinoid fenretinide (61) 61
vitamin-a (61) 61
cell line (59) 59
breast neoplasms - drug therapy (56) 56
breast neoplasms - pathology (56) 56
drug synergism (55) 55
metabolism (55) 55
vitamin a - blood (55) 55
blotting, western (54) 54
carcinoma-cells (54) 54
gene-expression (53) 53
trans-retinoic acid (53) 53
induced apoptosis (52) 52
cells (50) 50
fenretinide - adverse effects (50) 50
analysis (49) 49
cancer-cells (49) 49
ceramide (49) 49
fenretinide-induced apoptosis (49) 49
tumors (49) 49
in-vitro (48) 48
proteins (48) 48
phase-i trial (47) 47
retinoids - pharmacology (47) 47
tamoxifen (46) 46
reactive oxygen species (45) 45
antineoplastic agents - administration & dosage (44) 44
fenretinide - pharmacokinetics (44) 44
growth-inhibition (44) 44
neuroblastoma - pathology (44) 44
retinoid (44) 44
signal transduction (44) 44
cell death (43) 43
cell proliferation - drug effects (43) 43
therapy (43) 43
activation (42) 42
fenretinide - chemistry (42) 42
health aspects (42) 42
oxidative stress (42) 42
treatment outcome (42) 42
13-cis-retinoic acid (40) 40
caspases - metabolism (40) 40
carcinoma (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1000) 1000
Chinese (5) 5
Japanese (5) 5
German (2) 2
Italian (2) 2
Czech (1) 1
French (1) 1
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3749 - 3756
Purpose Tamoxifen and fenretinide are active in reducing premenopausal breast cancer risk and work synergistically in preclinical models. The authors assessed... 
THERAPY | INHIBITION | N-(4-HYDROXYPHENYL) RETINAMIDE | CLINICAL-TRIAL | ONCOLOGY | BINDING PROTEIN-3 | AROMATASE | PHASE-I | EXPRESSION | SYNTHETIC RETINOID FENRETINIDE | GROWTH-FACTOR-I | Multivariate Analysis | Receptors, Estrogen - metabolism | Humans | Middle Aged | Insulin-Like Growth Factor Binding Protein 3 - blood | Receptor, ErbB-2 - metabolism | Premenopause - blood | Tamoxifen - administration & dosage | Incidence | Receptors, Progesterone - metabolism | Antineoplastic Agents, Hormonal - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Anticarcinogenic Agents - administration & dosage | Antineoplastic Agents, Hormonal - therapeutic use | Carcinoma, Lobular - prevention & control | Fenretinide - administration & dosage | Adult | Female | Anticarcinogenic Agents - adverse effects | Breast Neoplasms - diagnostic imaging | Odds Ratio | Anticarcinogenic Agents - therapeutic use | Double-Blind Method | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Proportional Hazards Models | Tamoxifen - blood | Treatment Outcome | Mammography | Anticarcinogenic Agents - blood | Antineoplastic Agents, Hormonal - blood | Breast Neoplasms - prevention & control | Biomarkers, Tumor - blood | Drug Synergism | Fenretinide - blood | Fenretinide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Tamoxifen - therapeutic use | Breast Neoplasms - blood | Tamoxifen - analogs & derivatives | Tamoxifen - adverse effects | Insulin-Like Growth Factor I - metabolism | Vitamin A - blood | Carcinoma, Intraductal, Noninfiltrating - prevention & control | Fenretinide - adverse effects | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2011, Volume 17, Issue 21, pp. 6858 - 6866
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4550 - 4555
Journal Article
Journal Article
Journal Article